Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 2/20 | 0.64 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.64 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.64 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.64 |
| ▸ | F2 | P00734 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 2/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.56 |
| ▸ | DPP8 | Q6V1X1 | 6/20 | 0.53 |
| ▸ | DPP9 | Q86TI2 | 6/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.52 |
| ▸ | FLT1 | P17948 | 1/20 | 0.52 |
| ▸ | FLT4 | P35916 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 1/20 | 0.52 |
| ▸ | PLG | P00747 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30256099 | 0.93 | F2 (0.65) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL4552880 | 0.93 | F2 (0.58) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL18268937 | 0.91 | TDP1 (0.59) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL30574542 | 0.86 | TDP1 (0.71) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL24495340 | 0.86 | F2 (0.49) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL1727527 | 0.86 | TDP1 (0.67) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL10002269 | 0.86 | TDP1 (0.67) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL13888577 | 0.86 | TDP1 (0.67) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL14563108 | 0.85 | TDP1 (0.50) | PRSS1PRSS2PRSS3TPSAB1F2 | |
| SCHEMBL19751698 | 0.85 | F2 (0.73) | PRSS1PRSS2PRSS3TPSAB1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025080894-A1 | DETECTION OF DISEASE STATE MACROMOLECULES BINDING TO NORMAL MACROMOLECULES AS A BIOMARKER FOR DISEASE IDENTIFICATION | VERAVAS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-11795190-B2 | D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2023-10-24 | — | — | US | disclosed |
| US-20230305005-A1 | CORONAVIRUS POINT-OF-CARE AGGLUTINATION ASSAY | VERAVAS, INC. | 2023-09-28 | — | — | US | disclosed |
| EP-4196496-A1 | CORONAVIRUS POINT-OF-CARE AGGLUTINATION ASSAY | Veravas, Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| CN-116018354-A | Coronavirus immediate test agglutination assay | 维拉维斯公司 | 2023-04-25 | — | — | CN | disclosed |
| WO-2022036330-A1 | CORONAVIRUS POINT-OF-CARE AGGLUTINATION ASSAY | VEREVAS, INC. (US) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795190-B2 | D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation | DCPS, G6PD, M6PR | PRSS1 4278/4885PRSS2 4766/4885PRSS3 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.